SCHEMBL19976357

SCHEMBL19976357

Bc1nc2c(c(=O)[nH]c(=O)n2C)n1COCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
HPGD P15428 3/20 0.57
MAPK1 P28482 2/20 0.56
CYP2C9 P11712 2/20 0.51
HSD17B10 Q99714 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
NPSR1 Q6W5P4 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8266888 0.84 ALDH1A1 (0.62) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL4705592 0.84 KDM4E (0.62) ALDH1A1HPGDMAPK1CYP2C9LMNA
SCHEMBL15840964 0.76 GAA (0.57) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL14479261 0.76 ALDH1A1 (0.49) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL8684133 0.74 ALDH1A1 (0.47) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL19375412 0.73 ATM (0.71) ALDH1A1HPGDMAPK1HSD17B10SMN1; SMN2
SCHEMBL7464093 0.71 MAPK1 (0.57) ALDH1A1HPGDMAPK1SMN1; SMN2LMNA
SCHEMBL8439255 0.70 KDM4E (0.70) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL20725308 0.70 ALDH1A1 (0.62) ALDH1A1HPGDMAPK1CYP2C9HSD17B10
SCHEMBL21389539 0.70 ALDH1A1 (0.62) ALDH1A1HPGDMAPK1CYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10335413-B2 Substituted xanthine derivatives CONCERT PHARMACEUTICALS, INC. (US) 2019-07-02 US disclosed
US-9918987-B2 Substituted xanthine derivatives CONCERT PHARMACEUTICALS, INC. (US) 2018-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10335413-B2 Substituted xanthine derivatives XDH, HPRT1, CXCR3 ALDH1A1 699/4885HPGD 245/4885MAPK1 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.